Whitebox Advisors’s Estrella Immunopharma Warrant ESLAW Stock Holding History

Whitebox Advisors’s Portfolio ESLAW Stock Details ESLAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.5K	Hold	42,293	–	–	﹤0.01%	641
2026 Q1	$3.17K	Hold	42,293	–	–	﹤0.01%	556
2025 Q4	$2.12K	Hold	42,293	–	–	﹤0.01%	487
2025 Q3	$2.19K	Hold	42,293	–	–	﹤0.01%	423
2025 Q2	$2.01K	Hold	42,293	–	–	﹤0.01%	376
2025 Q1	$3.26K	Hold	42,293	–	–	﹤0.01%	296
2024 Q4	$3.89K	Sell	42,293 -3,183	-7%	-$271	﹤0.01%	244
2024 Q3	$2.92K	Hold	45,476	–	–	﹤0.01%	257
2024 Q2	$3.14K	Hold	45,476	–	–	﹤0.01%	268
2024 Q1	$3.02K	Hold	45,476	–	–	﹤0.01%	272
2023 Q4	$1.36K	Buy	+45,476	New	+$3.54K	﹤0.01%	273
2023 Q3	–	Sell	-45,476	Closed	-$2.52K	–	391
2023 Q2	$2.52K	Hold	45,476	–	–	﹤0.01%	352
2023 Q1	$4.65K	Hold	45,476	–	–	﹤0.01%	427
2022 Q4	$2.37K	Hold	45,476	–	–	﹤0.01%	622
2022 Q3	$3K	Hold	45,476	–	–	﹤0.01%	795
2022 Q2	$11K	Hold	45,476	–	–	﹤0.01%	641
2022 Q1	$10K	Hold	45,476	–	–	﹤0.01%	817
2021 Q4	$23K	Buy	+45,476	New	+$22.4K	﹤0.01%	710

Other funds holding ESLAW

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

RSWM

Robertson Stephens Wealth Management San Francisco, California $4.06B AUM 32.22% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

SIA

SkyView Investment Advisors Shrewsbury, New Jersey $128M AUM 19.21% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Whitebox Advisors's ESLAW Position: Q2 2026 in Review

Whitebox Advisors held its Estrella Immunopharma Warrant (ESLAW) position steady in Q2 2026 at 42,293 shares worth $5.5K. The position accounts for ﹤0.01% of the portfolio, ranked #641.

Whitebox Advisors first reported a position in ESLAW in Q4 2021 and has held it in 18 quarters since. The position peaked at $23K in Q4 2021. 8 funds tracked by Wall St. Rank hold ESLAW as of Q2 2026.

Whitebox Advisors held 42,293 shares of Estrella Immunopharma Warrant worth $5.5K as of Q2 2026.
Whitebox Advisors left its Estrella Immunopharma Warrant share count unchanged in Q2 2026.
Estrella Immunopharma Warrant made up ﹤0.01% of Whitebox Advisors's portfolio in Q2 2026, its #641 holding.
Whitebox Advisors first reported a position in Estrella Immunopharma Warrant in Q4 2021 and has held it in 18 quarters since.
Whitebox Advisors's Estrella Immunopharma Warrant position peaked at $23K in Q4 2021.
8 funds tracked by Wall St. Rank held Estrella Immunopharma Warrant as of Q2 2026.

Based on Whitebox Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.